Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1058Neoplasms 884Prostatic Neoplasms 510Lung Neoplasms 425Colorectal Neoplasms 359Motor Activity 226Head and Neck Neoplasms 195Uterine Cervical Neoplasms 192Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 175Pancreatic Neoplasms 162Ovarian Neoplasms 141Colonic Neoplasms 138Carcinoma, Hepatocellular 137Anxiety Disorders 124Rectal Neoplasms 119Hematologic Neoplasms 116Multiple Myeloma 109Stomach Neoplasms 104Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Urinary Bladder Neoplasms 88Pain 88Glioblastoma 87Endometrial Neoplasms 87Lymphoma 84Disease 84Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Fibroadenoma × 1 year × Clear all
NCT03044054 2026-05-01

HIFU-003

Theraclion

Phase NA Completed
113 enrolled

Fibroadenoma

NCT03868475 2026-03-09

VAPEX

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Withdrawn
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Cicatrix, Phyllodes Tumor, Patient Satisfaction, Fibroadenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡